X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (113) 113
index medicus (94) 94
female (80) 80
middle aged (79) 79
liver transplantation (78) 78
male (78) 78
life sciences (71) 71
gastroenterology & hepatology (64) 64
transplantation (64) 64
liver (54) 54
adult (52) 52
aged (38) 38
surgery (36) 36
risk factors (34) 34
hepatitis c (33) 33
human health and pathology (32) 32
cirrhosis (31) 31
hepatitis (28) 28
treatment outcome (28) 28
recurrence (26) 26
gastroenterology and hepatology (24) 24
liver transplantation - adverse effects (24) 24
retrospective studies (24) 24
france (21) 21
liver diseases (21) 21
ribavirin (20) 20
survival (20) 20
therapy (20) 20
hepatocellular carcinoma (18) 18
prospective studies (18) 18
recipients (18) 18
hepatitis c, chronic - drug therapy (17) 17
time factors (17) 17
transplants & implants (17) 17
antiviral agents - therapeutic use (16) 16
drug therapy, combination (16) 16
hepatitis c virus (16) 16
hépatology and gastroenterology (16) 16
multivariate analysis (16) 16
patients (16) 16
[sdv]life sciences [q-bio] (15) 15
immunosuppression (15) 15
syngeneic grafts (15) 15
allografts (14) 14
cancer (14) 14
care and treatment (14) 14
follow-up studies (14) 14
mortality (14) 14
infection (13) 13
liver cancer (13) 13
liver transplantation - mortality (13) 13
risk (13) 13
adolescent (12) 12
disease (12) 12
genotype (12) 12
immunosuppressive agents - therapeutic use (12) 12
interferon (12) 12
pharmacology & pharmacy (12) 12
[sdv.mhep.heg]life sciences [q-bio]/human health and pathology/hépatology and gastroenterology (11) 11
antiviral agents (11) 11
carcinoma, hepatocellular - pathology (11) 11
fibrosis (11) 11
impact (11) 11
liver cirrhosis (11) 11
prognosis (11) 11
relapse (11) 11
[ sdv ] life sciences [q-bio] (10) 10
analysis (10) 10
chemical and drug induced liver injury - etiology (10) 10
efficacy (10) 10
epidemiology (10) 10
follow-up (10) 10
immunology (10) 10
incidence (10) 10
infections (10) 10
infectious diseases (10) 10
liver neoplasms - pathology (10) 10
risk assessment (10) 10
survival analysis (10) 10
sustained virological response (10) 10
virus-infection (10) 10
young adult (10) 10
antiviral agents - adverse effects (9) 9
calcineurin inhibitors (9) 9
hepatitis c, chronic - complications (9) 9
liver transplantation - methods (9) 9
medical research (9) 9
tacrolimus (9) 9
virus diseases (9) 9
waiting lists (9) 9
abridged index medicus (8) 8
carcinoma, hepatocellular - mortality (8) 8
carcinoma, hepatocellular - surgery (8) 8
chronic hepatitis-c (8) 8
drug therapy (8) 8
hcv infection (8) 8
health aspects (8) 8
hepatology (8) 8
liver neoplasms - mortality (8) 8
liver neoplasms - surgery (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Patient Preference and Adherence, ISSN 1177-889X, 05/2014, Volume 2014, Issue default, pp. 763 - 773
Dominique Larrey,1,2 Marie-Pierre Ripault,1 Georges-Philippe Pageaux11Département d'Hépato-Gastroentérologie et Transplantation, Hôpital Saint Eloi,... 
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 143, Issue 4, pp. 986 - 994.e3
Journal Article
by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2015, Volume 13, Issue 11, pp. 1993 - 2001.e2
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 4, pp. 880 - 894.e6
Background & Aims Hepatocellular adenomas (HCAs) are benign liver tumors that can be assigned to molecular subtypes based on inactivating mutations in... 
Gastroenterology and Hepatology | HCC | SHH | Tumor Progression | Benign | HEDGEHOG PATHWAY | FOLLOW-UP | CANCER | TUMORS | SOMATIC MUTATIONS | INACTIVATION | INHIBITION | THERAPEUTIC TARGETS | GASTROENTEROLOGY & HEPATOLOGY | LIVER ADENOMATOSIS | ACTIVATING MUTATIONS | Liver Neoplasms - classification | Hepatocyte Nuclear Factor 1-alpha - genetics | Adenoma - genetics | Cytokine Receptor gp130 - genetics | Humans | Middle Aged | Transcriptome | Hedgehog Proteins - metabolism | Male | Liver Neoplasms - chemistry | GTP-Binding Protein alpha Subunits, Gs - genetics | Young Adult | Protein-Tyrosine Kinases - genetics | Telomerase - genetics | Cell Transformation, Neoplastic - genetics | Carcinoma, Hepatocellular - genetics | Hemorrhage - etiology | Aged, 80 and over | Adult | Chromogranins - genetics | Female | Carcinoma, Hepatocellular - chemistry | Inhibin-beta Subunits - genetics | Neoplasm Proteins - genetics | Child | STAT3 Transcription Factor - genetics | Liver Neoplasms - genetics | Signal Transduction | Zinc Finger Protein GLI1 - genetics | Risk Factors | Janus Kinase 2 - genetics | Gene Fusion | Adenoma - chemistry | beta Catenin - genetics | Sequence Analysis, RNA | Adenoma - classification | Adolescent | Carcinoma, Hepatocellular - pathology | Aged | Mutation | Liver cancer | Liver | Risk factors | Adenoma | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Hépatology and Gastroenterology | Tissues and Organs
Journal Article
Liver Transplantation, ISSN 1527-6465, 10/2016, Volume 22, Issue 10, pp. 1367 - 1378
Journal Article